What is Evommune 's net income?

Evommune (EVMN) reported net income of -$6.99M in Q1 2026.

How has Evommune 's net income changed year-over-year?

Evommune 's net income decreased by 5414.0% year-over-year, from -$126.78K to -$6.99M.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Evommune EVMN Net Income

Net Income at other companies

PfizerPFE

$2.69B-9.4%

Bausch + LombBLCO

-$71M+66.5%

BillionToOne, Inc. BLLN

$17.97M+551%

Perrigo CompanyPRGO

-$398.6M-6,128%

Hims & Hers HealthHIMS

-$92.12M-286%

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's net income?: Evommune (EVMN) reported net income of -$6.99M in Q1 2026.
How has Evommune 's net income changed year-over-year?: Evommune 's net income decreased by 5414.0% year-over-year, from -$126.78K to -$6.99M.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.